HS, R., KI, P., M, G., S, N., M, P., G, H., . . . 3rd, B. H. (2014). Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: Insights from BOLERO-2. Annals of oncology : official journal of the European Society for Medical Oncology, 25(4), 808. https://doi.org/10.1093/annonc/mdu009
Chicago Style (17th ed.) CitationHS, Rugo, et al. "Incidence and Time Course of Everolimus-related Adverse Events in Postmenopausal Women with Hormone Receptor-positive Advanced Breast Cancer: Insights from BOLERO-2." Annals of Oncology : Official Journal of the European Society for Medical Oncology 25, no. 4 (2014): 808. https://doi.org/10.1093/annonc/mdu009.
MLA (9th ed.) CitationHS, Rugo, et al. "Incidence and Time Course of Everolimus-related Adverse Events in Postmenopausal Women with Hormone Receptor-positive Advanced Breast Cancer: Insights from BOLERO-2." Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 25, no. 4, 2014, p. 808, https://doi.org/10.1093/annonc/mdu009.
